Israel Englander’s scPharmaceuticals SCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-471,119
| Closed | -$2.67M | – | 6401 |
|
|
2025
Q3 | $2.67M | Sell |
471,119
-67,351
| -13% | -$345K | ﹤0.01% | 3776 |
|
|
2025
Q2 | $2.05M | Buy |
538,470
+454,080
| +538% | +$1.41M | ﹤0.01% | 3853 |
|
|
2025
Q1 | $222K | Sell |
84,390
-25,519
| -23% | -$83.1K | ﹤0.01% | 5258 |
|
|
2024
Q4 | $389K | Sell |
109,909
-31,227
| -22% | -$120K | ﹤0.01% | 4921 |
|
|
2024
Q3 | $644K | Buy |
141,136
+11,066
| +9% | +$53.5K | ﹤0.01% | 4623 |
|
|
2024
Q2 | $566K | Sell |
130,070
-59,014
| -31% | -$259K | ﹤0.01% | 4513 |
|
|
2024
Q1 | $949K | Sell |
189,084
-167,789
| -47% | -$940K | ﹤0.01% | 4333 |
|
|
2023
Q4 | $2.24M | Sell |
356,873
-107,686
| -23% | -$617K | ﹤0.01% | 3510 |
|
|
2023
Q3 | $3.31M | Sell |
464,559
-751,647
| -62% | -$5.92M | ﹤0.01% | 3107 |
|
|
2023
Q2 | $12.4M | Sell |
1,216,206
-437,807
| -26% | -$4.57M | 0.01% | 1805 |
|
|
2023
Q1 | $15M | Buy |
1,654,013
+828,288
| +100% | +$6.07M | 0.01% | 1587 |
|
|
2022
Q4 | $5.92M | Buy |
825,725
+800,408
| +3,162% | +$4.89M | ﹤0.01% | 2665 |
|
|
2022
Q3 | $165K | Sell |
25,317
-10,899
| -30% | -$58.2K | ﹤0.01% | 5758 |
|
|
2022
Q2 | $175K | Buy |
36,216
+11,445
| +46% | +$56.6K | ﹤0.01% | 5700 |
|
|
2022
Q1 | $141K | Sell |
24,771
-8,567
| -26% | -$42.1K | ﹤0.01% | 5994 |
|
|
2021
Q4 | $167K | Sell |
33,338
-204
| -0.6% | -$1.12K | ﹤0.01% | 6023 |
|
|
2021
Q3 | $223K | Sell |
33,542
-24,175
| -42% | -$144K | ﹤0.01% | 6046 |
|
|
2021
Q2 | $353K | Buy |
+57,717
| New | +$348K | ﹤0.01% | 5617 |
|
|
2020
Q2 | – | Sell |
-35,059
| Closed | -$259K | – | 4548 |
|
|
2020
Q1 | $259K | Buy |
+35,059
| New | +$254K | ﹤0.01% | 3259 |
|
|
2019
Q3 | – | Sell |
-33,780
| Closed | -$108K | – | 4508 |
|
|
2019
Q2 | $108K | Buy |
+33,780
| New | +$110K | ﹤0.01% | 3880 |
|
|
2018
Q3 | – | Sell |
-19,300
| Closed | -$109K | – | 4223 |
|
|
2018
Q2 | $109K | Buy |
+19,300
| New | +$198K | ﹤0.01% | 3639 |
|
|
2018
Q1 | – | Sell |
-38,182
| Closed | -$462K | – | 4032 |
|
|
2017
Q4 | $462K | Buy |
+38,182
| New | +$539K | ﹤0.01% | 3133 |
|
Israel Englander's SCPH Position: Q4 2025 in Review
Israel Englander sold out of scPharmaceuticals (SCPH) in Q4 2025, closing a stake of 471,119 shares — an estimated $2.67M sold.
Israel Englander first reported a position in SCPH in Q4 2017 and held it in 22 quarters. The position peaked at $15M in Q1 2023. 0 funds tracked by Wall St. Rank hold SCPH as of Q4 2025.
- Israel Englander reported no remaining scPharmaceuticals position as of Q4 2025 after selling out during the quarter.
- Israel Englander sold 471,119 scPharmaceuticals shares in Q4 2025, an estimated $2.67M.
- Israel Englander first reported a position in scPharmaceuticals in Q4 2017 and held it in 22 quarters.
- Israel Englander's scPharmaceuticals position peaked at $15M in Q1 2023.
- 0 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2025.
Based on Millennium Management's 13F filing for Q4 2025, filed 17 Feb 2026.